Insider Selling: Revvity, Inc. (NYSE:RVTY) Insider Sells $262,206.42 in Stock

Revvity, Inc. (NYSE:RVTY) insider Tajinder S. Vohra sold 2,154 shares of the company’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $121.73, for a total transaction of $262,206.42. Following the transaction, the insider now owns 19,652 shares of the company’s stock, valued at approximately $2,392,237.96. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Revvity Trading Up 1.1 %

Shares of NYSE RVTY opened at $121.51 on Friday. The business’s 50 day moving average price is $121.36 and its 200-day moving average price is $112.46. Revvity, Inc. has a fifty-two week low of $79.50 and a fifty-two week high of $128.15. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.98 and a current ratio of 2.27. The company has a market cap of $14.99 billion, a price-to-earnings ratio of 100.42, a PEG ratio of 3.35 and a beta of 1.05.

Revvity (NYSE:RVTY) last released its earnings results on Monday, July 29th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.10. The business had revenue of $691.70 million during the quarter, compared to the consensus estimate of $690.33 million. Revvity had a return on equity of 7.34% and a net margin of 6.26%. The business’s revenue for the quarter was down 2.5% compared to the same quarter last year. During the same period last year, the company earned $1.21 earnings per share. On average, sell-side analysts expect that Revvity, Inc. will post 4.75 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 8th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.23%. The ex-dividend date of this dividend is Friday, October 18th. Revvity’s dividend payout ratio is presently 23.14%.

Analyst Ratings Changes

A number of research analysts have recently weighed in on RVTY shares. TD Cowen raised their price objective on Revvity from $130.00 to $141.00 and gave the company a “buy” rating in a research report on Tuesday, July 30th. Wells Fargo & Company initiated coverage on Revvity in a report on Tuesday, August 27th. They set an “equal weight” rating and a $130.00 price target for the company. Citigroup upped their price objective on Revvity from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, July 30th. Barclays raised their target price on shares of Revvity from $115.00 to $125.00 and gave the company an “equal weight” rating in a report on Tuesday, July 30th. Finally, JPMorgan Chase & Co. upped their price target on shares of Revvity from $105.00 to $120.00 and gave the company a “neutral” rating in a research note on Tuesday, July 30th. Eight analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Revvity has a consensus rating of “Moderate Buy” and an average price target of $125.53.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Rothschild Investment LLC bought a new position in shares of Revvity during the 2nd quarter worth $25,000. EverSource Wealth Advisors LLC lifted its stake in shares of Revvity by 74.2% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 392 shares of the company’s stock worth $41,000 after purchasing an additional 167 shares during the last quarter. Family Firm Inc. purchased a new position in Revvity in the second quarter valued at about $43,000. Fairfield Financial Advisors LTD purchased a new position in Revvity in the second quarter worth $43,000. Finally, EntryPoint Capital LLC acquired a new position in shares of Revvity during the first quarter worth $48,000. Institutional investors own 86.65% of the company’s stock.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.